|1.||Vizel', A A: 3 articles (01/2002 - 01/2000)|
|2.||Gerken, Fronke: 2 articles (03/2004 - 01/2004)|
|3.||Lebedenko, A: 1 article (01/2015)|
|4.||Semernik, O: 1 article (01/2015)|
|5.||Pipopsuthipaiboon, Sutat: 1 article (02/2011)|
|6.||Ratanasaenglert, Kanokwan: 1 article (02/2011)|
|7.||Suthamsmai, Tasneeya: 1 article (02/2011)|
|8.||Maneechotesuwan, Kittipong: 1 article (02/2011)|
|9.||Szabó, Barna: 1 article (12/2009)|
|10.||Pénzes, István: 1 article (12/2009)|
|1.||Asthma (Bronchial Asthma)
01/01/1986 - "Duovent appears to be an effective drug in the treatment of bronchial asthma in children, both clinically and functionally."
01/01/1997 - "[Comparative efficacy of single Berodual inhalation in patients with bronchial asthma: nebulization against dose-adjusted aerosol]."
07/01/2008 - "Venezuela's Ministry of Health ambulatory facilities care for 80 % or more of a mostly urban and impoverished population of 26 million inhabitants, registering close to a million acute asthma visits per year; a nebulised fixed fenoterol-ipratropium bromide combination (Bero-dual, Boehringer-Ingelheim) in repeated dosing is the standard treatment. "
01/01/1995 - "[Role of Bronchodual in the long-term treatment of asthma in children]."
04/01/1988 - "Comparison of fenoterol, ipratropium bromide and their combination in patients with bronchial asthma."
01/01/1986 - "Efficacy and compliance to prolonged Duovent treatment of bronchospasm. "
01/01/1986 - "In conclusion, Duovent is a rational and effective combination in the treatment of bronchospasm."
03/15/1983 - "[Fenoterol, ipratropium bromide and their combination in the therapy of bronchospasm]."
01/01/1986 - "Duovent and salbutamol were compared in 15 patients with stabilized, but partially reversible chronic bronchospasm to verify the persistence of therapeutic effect, bronchodilator efficacy and patient compliance to prolonged treatment with these drugs. "
01/01/1986 - "Duovent compared to carbuterol in the treatment of bronchospasm."
01/01/1999 - "To study clinical efficiency of 12-month administration of berodual in chronic obstructive bronchitis (COB). "
01/01/2000 - "Berodual is effective as monotherapy of chronic obstructive bronchitis."
01/01/1999 - "[Experience in long-term use of berodual in the treatment of patients with chronic obstructive bronchitis]."
01/01/2000 - "[Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation]."
01/01/1999 - "[Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis]."
01/01/1984 - "Peak expiratory flow rates were increased to a statistically significant degree during the Duovent period and, during this period, there was a significant reduction in day-time cough, night-time wheeze and night wakings . "
01/01/2002 - "Berodual caused no side effects, salgim provoked short-term cough in 6(19.4%) patients. "
01/01/1986 - "Cough, day-time and nocturnal dyspnoea and the number of additional sprays required were better controlled with Duovent. "
01/01/1986 - "In the subjects treated with Duovent, there was a clear reduction in cough and dyspnea and a significant increase in PEF. "
02/01/2011 - "Our data suggest that nebulized Ipraterol offers a statistically significant improvement in pulmonary function without significant systemic absorption causing hypokalemia, with the improvement being comparable to that achieved with nebulized Berodual."
02/01/2011 - "We also found that there were no significant differences in the degree of improvement in FEV1 and hypokalemia following treatment with Ipraterol and Berodual. "
|1.||Ipratropium (Ipratropium Bromide)
|3.||Histamine (Histamine Dihydrochloride)
|4.||ipratropium drug combination fenoterol
|6.||HFA 134a (hydrofluoroalkane)
|1.||Nebulizers and Vaporizers (Inhaler)
|2.||Metered Dose Inhalers (Metered Dose Inhaler)
|5.||Respiratory Therapy (Therapy, Respiratory)